- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06944054
Evaluation of the Effect of Duration of Stabilising Tapes on Skin Damage in Neonates
Evaluation of the Effect of the Time the Stabilizer Tapes Stay on the Skin on Skin Damage in Newborns
Study Overview
Detailed Description
Aim: The research was conducted to evaluate the relationship between the duration of the fixing tapes of the probes attached to the chest, abdominal and lower extremity regions of newborns for temperature monitoring and skin damage.
Materials and Methods: The research was conducted in a randomized controlled experimental design between August 2023 and December 2023. The 37th-40th year is being treated in the Neonatal Intensive Care Unit of Gynecology Training and Research Hospital. It was done with 60 newborns between weeks. Newborns were assigned to the experimental group (n = 30) and control group (n = 30) by simple randomization. In the experimental group, the duration of the fixative tapes to stay on the skin was 2 hours, and in the control group, the duration of the fixative tapes to stay on the skin was 4 hours, which is applied in the clinical routine. Stabilizer tapes were adhered to three different areas on the skin and changed clockwise. Data were collected using the Newborn Information Form, Newborn Skin Condition Assessment Scale (NSCS) and Newborn Skin Risk Assessment Scale (NSRAS). Descriptive statistics, repeated measures ANOVA, Pearson Correlation test and Pearson Chi Square test statistics were used in data analysis. p<0.05 level was considered statistically significant.
Key Words: Newborn, Skin Damage, Epidermis, Stabilization Tapes, Newborn Nurse
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06010
- Saglik Bilimleri Universitesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Newborns between 37th and 40th week
- Use of a temperature monitoring probe
- Parents volunteering their infants to participate in the study and signing the consent form
Exclusion Criteria:
- Presence of conditions that may make skin condition assessment difficult (presence of any laceration, fracture or genetic dermatological disease that disrupts skin integrity, congenital skin damage, hydrops, anomalies of the anterior abdominal wall, scleroderma)
- Parents not volunteering for the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 2 hourly interval stabiliser band change group
Every 2 hours, the heat probes were replaced.
Hypoallergenic patches were removed with a silicone-based spray used in the clinic.
The application continued for 24 hours.
In total, 12 heat probe displacements were made to different points in the abdominal, chest or lower extremity region.
Heat probe stabilising tapes were attached to different points in a clockwise direction.
At the end of 24 hours, the skin conditions of the newborns were re-evaluated with scales and recorded.
This application continued for 3 days.
|
Every 2 hours, the heat probes were replaced.
Hypoallergenic patches were removed with a silicone-based spray used in the clinic.
The application continued for 24 hours.
In total, 12 heat probe displacements were made to different points in the abdominal, chest or lower extremity region.
Heat probe stabilising tapes were attached to different points in a clockwise direction.
At the end of 24 hours, the skin conditions of the newborns were re-evaluated with scales and recorded.
This application continued for 3 days.
|
|
No Intervention: 4 hourly interval stabiliser band change group
Hypoallergenic patches were removed with a silicone-based spray used in the clinic.
The application continued for 24 hours.
A total of 6 heat probe displacements were applied to different points in the abdomen, chest or lower extremities at 4-hour intervals.
Heat probe fixation bands were attached clockwise to different points.
At the end of 24 hours, the skin condition of the newborns was evaluated with scales.
This application continued for 3 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal Skin Condition Assessment Scale (NSCS)
Time Frame: 3 days
|
The NSCS is a 3-point Likert-type scale that evaluates dryness, redness, peeling and deterioration of the skin.
Evaluation of the scale score: each criterion was scored with 1 being the best and 3 being the worst.
A maximum of 9 and a minimum of 3 points can be scored in the total score.
A score of 9 indicates a poor skin score, while a score of 3 indicates a good skin score.
An increase in the scale score means that the skin condition is poor.
|
3 days
|
|
Neonatal Skin Risk Assessment Scale
Time Frame: 3 days
|
These are general physical condition, mental state, mobility, activity, nutrition, humidity.
Each parameter in the scale is scored from 1 to 4. The score that can be obtained from the scale varies between 6 and 24.
A high score on the scale indicates an increased risk of skin integrity disruption in the newborn, while a low score means that the risk of skin integrity disruption is low.
was used.
|
3 days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SBU-HF-KK-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Newborns
-
Fortaleza UniversityCompletedOrofacial Difficulties in Newborns | Maternal Breastfeeding in Newborns | Newborns in Rooming-in
-
Johnson & Johnson Consumer Inc. (J&JCI)University of SheffieldTerminated
-
Hospices Civils de LyonCompleted
-
Marmara UniversityNot yet recruiting
-
Karadeniz Technical UniversityCompleted
-
Peking University Third HospitalUnknownEchocardiography of NewbornsChina
-
Groupe Hospitalier Paris Saint JosephCompletedNewborns | Delivery | MotherhoodFrance
-
University Hospital, MontpellierRecruitingSpinal Anesthesia | Infant | NewbornsFrance
-
LactaLogics, IncRenown Regional Medical CenterCompleted
-
University Hospital, MontpellierRecruitingIntensive Care | Newborns | NeonatologyFrance
Clinical Trials on Group 1
-
Arkansas Children's Hospital Research InstituteTerminated
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Weill Medical College of Cornell UniversityTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Kubra GunesNot yet recruitingCardiovascular Surgery
-
Biruni UniversityCompleted
-
Beijing HospitalThe First Hospital of Jilin University; Jilin University; Chinese Academy of...Not yet recruitingAsthma | Allergic Disease
-
Riphah International UniversityCompleted
-
Marmara UniversityCompletedStair up and Down, Amputation | Amputation,Stair up and DownTurkey
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownRetinal Detachment | High Myopia | Macular HolesChina